Yihuan Xu

Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients

Gloria J. Morris, Sashi Naidu, Allan Topham et al. · Cancer · 2007 · 608 citations

Medicine, Oncology, Pathology +16

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

Lawrence Steinman, Edward Fox, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2022 · 199 citations

Life Sciences, Immunology, Pharmacotherapy +17

A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

Andrew X. Zhu, Richard S. Finn, Mary F. Mulcahy et al. · Clinical Cancer Research · 2013 · 165 citations · Full text

Medicine, Oncology, Pharmacology +17

Guanylyl Cyclase C Suppresses Intestinal Tumorigenesis by Restricting Proliferation and Maintaining Genomic Integrity

Peng Li, Stephanie Schulz, Alessandro Bombonati et al. · Gastroenterology · 2007 · 141 citations · Full text

Medicine, Genetics, Oncology +17

Ramucirumab (RAM) plus FOLFOX as front-line therapy (Rx) for advanced gastric or esophageal adenocarcinoma (GE-AC): Randomized, double-blind, multicenter phase 2 trial.

Harry H. Yoon, Johanna C. Bendell, Fadi S. Braiteh et al. · Journal of Clinical Oncology · 2014 · 81 citations

Medicine, Oncology, Pharmacotherapy +16